Lowery, Ryan,Wilson, Jacob,Wells, Shawn,Underwood, Brian,Harding, Christopher N.,Lacore, Terry
申请号：
AU2017253109
公开号：
AU2017253109A1
申请日:
2017.04.19
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
In various implementations, beta-hydroxybutyrate, related compounds, and/or one or more other compounds may be administered to an individual to cause weight loss, weight maintenance, elevate blood ketone levels, maintain blood ketone levels, reduce blood glucose levels, maintain blood glucose levels, improve energy, focus, mood, cognitive function, or aide with neurological or inflammatory disorders and/or combinations thereof. Other compounds may include short chain fatty acids, short chain triglycerides, medium chain fatty acids, medium chain triglycerides, long chain fatty acids, long chain triglycerides, berberine, metabolites of berberine (e.g., dihydroberberine), and/or combinations thereof.
